Currencies, mainly as a result of the strength of the Swiss franc relative to the US dollar, but also to the Euro and other currencies, will weigh on consolidated sales, whereas acquisitions net of divestitures, mainly due to Novartis Medical Nutrition and Gerber, will boost sales growth.